Form 10QSB - Optional form for quarterly and transition reports of small business issuers:
SEC Accession No. 0000927016-97-001479
Filing Date
1997-05-15
Accepted
1997-05-15 00:00:00
Documents
4
Period of Report
1997-03-31
SROs
NASD

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT 10QSB 31260
2 J. MELVILLE ENGLE LOAN EX-10.1 544
3 COMPUTATION OF PRIMARY AND FULLY DILUTED EPS EX-11 2510
4 FINANCIAL DATA SCHEDULE EX-27 2065
  Complete submission text file 0000927016-97-001479.txt   38237
Mailing Address 236 WEST CUMMINGS PARK WOBURN MA 01801
Business Address 236 WEST CUMMINGS PARK WOBURN MA 01801 6179326616
ANIKA THERAPEUTICS INC (Filer) CIK: 0000898437 (see all company filings)

EIN.: 043145961 | State of Incorp.: MA | Fiscal Year End: 0831
Type: 10QSB | Act: 34 | File No.: 000-21326 | Film No.: 97606676
SIC: 2836 Biological Products, (No Diagnostic Substances)